Nalaganje...
Preclinical evaluation of marketed sodium channel blockers in a rat model of myotonia discloses promising antimyotonic drugs
Although the sodium channel blocker mexiletine is considered the first-line drug in myotonia, some patients experiment adverse effects, while others do not gain any benefit. Other antimyotonic drugs are thus needed to offer mexiletine alternatives. In the present study, we used a previously-validate...
Shranjeno v:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Academic Press
2014
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4004800/ https://ncbi.nlm.nih.gov/pubmed/24613829 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.expneurol.2014.02.023 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|